论文部分内容阅读
目的探讨茵栀黄联合双歧杆菌三联活菌散治疗新生儿黄疸的临床治疗效果。方法选取2014年1月至2014年10月在我院母婴同室80例新生儿黄疸为研究对象,随机分为2组,即对照组和治疗组。对照组服用茵栀黄口服液进行治疗,治疗组则采用双歧杆菌三联活菌散联合茵栀黄进行治疗,对两组的治疗效果进行评价。结果对照组总有效率为80%,治疗组总有效率为98%;治疗组血清胆红素下降、黄疸消退时间均优于对照组,两组总有效率比较差异有统计学意义。对照组和治疗组在治疗过程中都没有不良反应发生。结论双歧杆菌三联活菌散联合茵栀黄治疗新生儿病理性黄疸的效果显著。
Objective To investigate the curative effect of Yinzhihuang combined with Bifidobacterium triple viable powder in the treatment of neonatal jaundice. Methods From January 2014 to October 2014, 80 neonates with neonatal jaundice in our hospital were randomly divided into two groups: control group and treatment group. The control group was treated with Yinzhihuang Oral Liquid. The treatment group was treated with Bifidobacterium triple inactivated probiotics combined with Yinzhihuang, and the therapeutic effects were evaluated. Results The total effective rate of the control group was 80%, and the total effective rate of the treatment group was 98%. The serum bilirubin and jaundice subsided in the treatment group were all better than the control group. The total effective rate of the two groups was statistically significant. The control group and treatment group in the course of treatment without adverse reactions. Conclusion Bifidobacterium triple live bacteria powder combined Yinzhihuang treatment of neonatal pathological jaundice effect is significant.